论文部分内容阅读
世界卫生组织最新公布的数据显示,全球年新发胃癌患者达950 000例以上,有超过一半的病例发生于东亚国家,其中仅我国的发病例数每年就超过40万,占全球每年新发胃癌病例的40%。胃癌已成为不容忽视的严重危害国民生命和健康的疾病。目前,国内外针对胃癌尚缺乏特异性靶向治疗的分子靶点,临床治疗手段相对单一。其中,早中期胃癌主要以手术切除治疗为主,而对于丧失手术治疗时机的晚期胃癌患者则以化疗为主。研究者们
According to the latest data released by the World Health Organization, there are more than 950,000 new gastric cancer cases in the world each year. More than half of the cases occur in East Asian countries, of which the number of cases in China alone exceeds 400,000 annually, accounting for the annual new global gastric cancer 40% of cases. Gastric cancer has become a disease that can not be neglected and seriously endangers the life and health of the people. At present, there is no specific molecular target for targeted therapy in gastric cancer at home and abroad, and the clinical treatment methods are relatively simple. Among them, early-stage gastric cancer is mainly treated by surgical resection, while chemotherapy is the mainstay of patients with advanced gastric cancer who have lost the opportunity of surgical treatment. Researchers